{
    "nctId": "NCT05663294",
    "briefTitle": "PBI for Breast In Situ Carcinoma of Intermediate Low Risk as Local Adjuvant Treatment",
    "officialTitle": "Partial Radiotherapy for Breast In Situ Carcinoma of Intermediate Low Risk as Local Adjuvant Treatment",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "Local Control rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \\>40\n* Pathologically confirmed DCIS:\n\n  1. low risk (lesions of \u22643 cm diameter, resection margins of at least 2 mm, nuclei grade: G1, G2)\n  2. intermediate risk (lesions of \u22641 cm diameter, resection margins of at least 2 mm, nuclei grade: 3)\n* Written informed consent\n\nExclusion Criteria:\n\n* Prior thoracic radiation therapy\n* Preoperative systemic treatments (i. e., chemotherapy, endocrine therapy);\n* Autoimmune disease, vasculitis, collagenopathy or scleroderma that may predispose to late sequelae\n* No other cancers in the last 5 years",
    "sex": "FEMALE",
    "minimumAge": "41 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}